Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
18,320,102
-
Shares change
-
-444,779
-
Total reported value, excl. options
-
$154,069,337
-
Value change
-
-$5,403,918
-
Put/Call ratio
-
151%
-
Number of buys
-
30
-
Number of sells
-
-43
-
Price
-
$8.41
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2017
109 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q4 2017.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,320,102 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (5,032,313 shares), FMR LLC (2,629,542 shares), JPMORGAN CHASE & CO (2,339,068 shares), BlackRock Inc. (2,314,166 shares), Vanguard Group Inc (1,361,357 shares), STATE STREET CORP (438,277 shares), NORTHERN TRUST CORP (338,693 shares), Prosight Management, LP (301,349 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (290,731 shares), and MORGAN STANLEY (253,078 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.